Gilbert Lynn Marks

Insider Reports History

Entity
Individual
Location
821 Washington St., Cape May, NJ
Signature
/s/ Lucy Day, Attorney-in-Fact for Gilbert Lynn Marks
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gilbert Lynn Marks:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Director Common Stock 41.5K $55.7K $1.34 Apr 10, 2025 Direct
AN2 Therapeutics, Inc. Director Stock Option (Right to Buy) 64.5K Jun 19, 2024 Direct

Insider Reports Filed by Gilbert Lynn Marks

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANTX AN2 Therapeutics, Inc. Apr 10, 2025 1 $0 4 Apr 11, 2025 Director
ANTX AN2 Therapeutics, Inc. Dec 19, 2024 1 $0 4 Dec 23, 2024 Director
ANTX AN2 Therapeutics, Inc. Jun 19, 2024 1 $0 4 Jun 21, 2024 Director
ANTX AN2 Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
ANTX AN2 Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Director
ANTX AN2 Therapeutics, Inc. Mar 24, 2022 0 $0 3 Mar 24, 2022 Director